Genetics > Nova Content
In a significant ruling on December 19, 2023, the German patent court invalidated a crucial patent that formed the core of... Read More »
In a groundbreaking legal battle, the District Court of The Hague is set to hear Europe's first case... Read More »
Promosome LLC, a biotech firm represented by law firm Susman Godfrey, has just filed a patent infringement lawsuits against Moderna... Read More »
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More »
IN RE: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Before Prost, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board... Read More »
On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”), about which we reported here. Governor... Read More »
UPDATE: On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”). Click here for an... Read More »
Anyone familiar with the fate of claims to primers used in PCR, to amplify a stretch of target DNA in order to determine whether or not a significant mutation is... Read More »
In ex parte Ho, the subject of my last post, the PTAB reversed the Examiner’s rejection of claims to a population of bone marrow cells obtained by two-stage... Read More »
On July 18th, in appeal no. 2017-007443, the PTAB reversed the Examiner’s rejection to an improved method of manipulating the huge amount of DNA sequence... Read More »
A new infertility technique, mitochondrial replacement therapy (MRT), has been used to create so called “three-parent” babies. MRT is used in cases when... Read More »
The U.S. Food and Drug Administration (FDA) recently authorized 23andMe to market its Personal Genome Service Genetic Health Risk Report for BRCA1/BRCA2 (Selected... Read More »
On March 6, 2018, 23andMe, Inc. received the first-ever FDA authorization for a direct-to-consumer genetic test that analyzes gene mutations to help predict a... Read More »
Throughout the past year, substantial investment continued to pour into digital health and personalized medicine. Personalized medicine involves the discovery... Read More »
The FDA may begin certifying the laboratories that produce lab-developed tests (“LDTs”) instead of drafting regulatory rules to cover the tests... Read More »
On January 25, a team at the Chinese Academy of Sciences published an online paper that will appear in Cell, 172, 1-7 (Feb. 8, 2018) reported the cloning of two... Read More »
Written by Nicole R. Townes and Jason J. Jardine
Edited by Loni Morrow and Catherine Holland
On March 24, 2017, the U.S. Court of Appeals for the Ninth... Read More »
Lung cancer is the most commonly occurring cancer worldwide, in terms of both incidence and mortality, with 1.61 million new cases in 2008 and 1.38 million... Read More »
A tiny vibrating cantilever sensor could soon help doctors and field clinicians quickly detect harmful toxins. The list includes bacteria certain types of cancer from ... Read More »
A new type of nanoparticle-based conjugate is a promising alternative to RNA interference (RNAi) agents for controlling gene expression. Nanozymes are gold... Read More »